You are viewing the site in preview mode

Skip to main content

Table 6 Proviral load for each HLA-A allele and clinical status

From: HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina

Allele Population Mean PVL
AC ATLL HAM
HLA-A*02 1.42 12.49* 4.35 3.13
HLA-A*03 4.61* – – 4.61
HLA-A*11 – – 4.03* 4.03
HLA-A*23 – 0.34* – 0.34
HLA-A*24 6.64 0.34* – 4.54
HLA-A*25 1.29* – – 1.29
HLA-A*26 1.29* – – 1.29
HLA-A*29 – – 9.32** 9.32
HLA-A*31 1.29 33.98 15.1 12.28
HLA-A*32 – 9.82* – 9.82
HLA-A*33 1.85** 40.2* 11.12 12.88
HLA-A*68 4.61* 1.3* – 2.95
HLA-A*69 ND – – ND
  1. AC asymptomatics carriers, HAM HTLV-1 associated myelopathy, ATLL Adult T cell leukemia/lymphoma, NII Non-infected Individuals, HLA Human leukocyte antigen, PVL proviral load
  2. *Only the PVL of one allele was available, **Mean PVL of two alleles
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us